-
Signature
-
/s/ Nisha Antony, as Attorney-in-Fact
-
Issuer symbol
-
CRWV
-
Transactions as of
-
02 Dec 2025
-
Transactions value $
-
-$8,123,132
-
Form type
-
4
-
Filing time
-
04 Dec 2025, 21:49:19 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| McBee Brannin |
Chief Development Officer |
C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON |
/s/ Nisha Antony, as Attorney-in-Fact |
04 Dec 2025 |
0002058103 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+102,835 |
+56% |
|
288,016 |
02 Dec 2025 |
Direct |
F1 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+25,000 |
|
|
25,000 |
02 Dec 2025 |
Brannin J McBee 2022 Irrevocable Trust |
F1, F2 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+3,000 |
|
|
3,000 |
02 Dec 2025 |
Canis Major 2024 Irrevocable Trust LLC |
F1, F3 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+1,000 |
|
|
1,000 |
02 Dec 2025 |
Canis Major 2025 Family Trust LLC |
F1, F4 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+1,000 |
|
|
1,000 |
02 Dec 2025 |
Canis Minor 2025 Family Trust LLC |
F1, F5 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+25,000 |
|
|
25,000 |
02 Dec 2025 |
Canis Major 2025 GRAT |
F1, F6 |
| transaction |
CRWV |
Class A Common Stock |
Conversion of derivative security |
|
+8,335 |
|
|
8,335 |
02 Dec 2025 |
Canis Minor 2025 GRAT |
F1, F7 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$5,260 |
-69 |
-0.12% |
$76.23 |
59,931 |
02 Dec 2025 |
Canis Major SM Trust |
F8, F9, F10 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$9,773 |
-126 |
-0.21% |
$77.56 |
59,805 |
02 Dec 2025 |
Canis Major SM Trust |
F8, F10, F11 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$11,524 |
-147 |
-0.25% |
$78.4 |
59,658 |
02 Dec 2025 |
Canis Major SM Trust |
F8, F10, F12 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$3,812 |
-48 |
-0.08% |
$79.42 |
59,610 |
02 Dec 2025 |
Canis Major SM Trust |
F8, F10, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$3,380 |
-42 |
-0.07% |
$80.5 |
59,568 |
02 Dec 2025 |
Canis Major SM Trust |
F8, F10, F14 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$3,910 |
-48 |
-0.08% |
$81.46 |
59,520 |
02 Dec 2025 |
Canis Major SM Trust |
F8, F10, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$1,644 |
-20 |
-0.03% |
$82.24 |
59,500 |
02 Dec 2025 |
Canis Major SM Trust |
F8, F10, F16 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$1,090,592 |
-14,306 |
-5% |
$76.23 |
273,710 |
02 Dec 2025 |
Direct |
F8, F17 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$2,002,562 |
-25,818 |
-9.4% |
$77.56 |
247,892 |
02 Dec 2025 |
Direct |
F8, F11 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$2,365,548 |
-30,173 |
-12% |
$78.4 |
217,719 |
02 Dec 2025 |
Direct |
F8, F12 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$790,027 |
-9,947 |
-4.6% |
$79.42 |
207,772 |
02 Dec 2025 |
Direct |
F8, F13 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$701,934 |
-8,720 |
-4.2% |
$80.5 |
199,052 |
02 Dec 2025 |
Direct |
F8, F14 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$796,794 |
-9,781 |
-4.9% |
$81.46 |
189,271 |
02 Dec 2025 |
Direct |
F8, F15 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$336,366 |
-4,090 |
-2.2% |
$82.24 |
185,181 |
02 Dec 2025 |
Direct |
F8, F16 |
| holding |
CRWV |
Class A Common Stock |
|
|
|
|
|
1,800 |
02 Dec 2025 |
See Footnote |
F18 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-102,835 |
-1.1% |
|
9,322,825 |
02 Dec 2025 |
Class A Common Stock |
102,835 |
|
Direct |
F1, F19 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-25,000 |
-0.59% |
|
4,241,020 |
02 Dec 2025 |
Class A Common Stock |
25,000 |
|
Brannin J. McBee 2022 Irrevocable Trust |
F1, F2 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-3,000 |
-0.83% |
|
357,000 |
02 Dec 2025 |
Class A Common Stock |
3,000 |
|
Canis Major 2024 Irrevocable Trust LLC |
F1, F3 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-1,000 |
-0.83% |
|
119,600 |
02 Dec 2025 |
Class A Common Stock |
1,000 |
|
Canis Major 2025 Family Trust LLC |
F1, F4, F19 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-1,000 |
-0.75% |
|
133,000 |
02 Dec 2025 |
Class A Common Stock |
1,000 |
|
Canis Minor 2025 Family Trust LLC |
F1, F5, F19 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-25,000 |
-0.42% |
|
5,975,000 |
02 Dec 2025 |
Class A Common Stock |
25,000 |
|
Canis Major 2025 GRAT |
F1, F6 |
| transaction |
CRWV |
Class B Common Stock |
Conversion of derivative security |
|
-8,335 |
-0.83% |
|
991,665 |
02 Dec 2025 |
Class A Common Stock |
8,335 |
|
Canis Minor 2025 GRAT |
F1, F7 |
| holding |
CRWV |
Class B Common Stock |
|
|
|
|
|
2,280,300 |
02 Dec 2025 |
Class A Common Stock |
2,280,300 |
|
By Spouse |
F1, F19, F20 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
This Form 4 is Part 1 of 3 for this reporting person. Transactions by the reporting person reported on Table I are continued on Parts 2 and 3.